Paid Media Campaign Workflow Automation · AdTech Vendor
KNOREX
Cross-channel DSP and advertising automation platform for enterprises and agencies.
Available information varies by company and source.
Profile record updated:
Company facts
- Official name
- Knorex Ltd.
- Entity type
- COMPANY
- Founded
- 2009
- Headquarters
- Singapore
- Company size
- 50–200
- Market cluster / sector
- Paid Media Campaign Workflow Automation
- Market role
- AdTech Vendor
- Ticker
- KNRX
- Official website
- knorex.com
What KNOREX does
Knorex creates value by consolidating fragmented digital advertising workflows into a single platform for campaign execution across social, search, CTV/OTT, display, mobile and audio. It earns revenue from software access and from campaign activity conducted through the platform, using proprietary optimisation technology to improve media efficiency and reduce manual trading effort for customers.
Category differentiation
Knorex is not a consumer media publisher or a standalone AI model provider. It is a B2B advertising technology platform centred on DSP-style media execution, optimisation and creative automation.
Strategic context
AI-supported assessment from the existing company research; distinguish interpretation from sourced facts.
Knorex is a public adtech company whose core product is Knorex XPO, a cloud-based advertising management and execution platform used to plan, buy, run, measure and optimise campaigns across multiple digital channels. Its platform combines demand-side media buying, cross-channel workflow automation, reporting, attribution and dynamic creative capabilities, with a proprietary optimisation engine embedded into the product stack. The company primarily serves enterprise advertisers, digital marketing teams and media agencies.
Business model & monetisation
Knorex primarily monetises through a hybrid SaaS and media-activity model. Customers access the XPO platform as enterprise software, while additional revenue is generated from usage tied to advertising spend, campaign execution volume, platform utilisation and potentially premium modules such as AI optimisation, APIs, white-labelling and dynamic creative features.
- Platform subscriptions
- Software Subscription
- Media execution fees tied to campaign activity or spend
- Percentage Take-Rate
- Premium optimisation and enterprise modules
- Software Subscription
- Potential API or white-label capabilities
- Software Subscription
Products & capabilities
| Product | Description | Source |
|---|---|---|
| Knorex XPO | Knorex XPO is an AI-powered, cloud-based advertising management and execution platform that enables advertisers to plan, buy, execute, measure, and optimise campaigns across multiple digital channels from a single interface. It functions as a cross-channel demand-side platform combined with marketing automation, integrating programmatic inventory, social, search, CTV, and other media while providing unified reporting, attribution, and workflow automation. The platform is designed for self-service use by enterprises and agencies, consolidating fragmented adtech tools into one system with AI-driven optimisation. |
|
| Knorex KAIROS | Knorex KAIROS is a proprietary machine learning and artificial intelligence engine embedded within the XPO platform that powers automated decisioning, optimisation, and predictive analytics. It analyses cross-channel campaign data to drive real-time bidding, budget allocation, audience modelling, and creative personalisation, enabling continuous performance improvement without manual intervention. KAIROS acts as the algorithmic core of Knorex’s advertising stack, enhancing efficiency and scalability of campaign execution. |
|
| Knorex Dynamic Creative Optimisation | Knorex Dynamic Creative Optimisation is a technology module within the XPO ecosystem that automates the creation and delivery of personalised ad creatives at scale. It uses templates and data feeds to generate multiple creative variations in real time, enabling one-to-one messaging across audiences, locations, and contexts. The solution supports rapid production and testing of creative assets while integrating directly with cross-channel campaign execution workflows. |
|
Programmatic Stack & IAB Governance
Observed registry records, IAB TCF v2.2 declarations, and indexed supply paths for KNOREX.
Observed registration in the IAB Europe Global Vendor List (GVL) for KNOREX.
POLARIS7 WORKSPACE
Go deeper on KNOREX and its market context
Access extended corporate structures, historical M&A and partnership links, technical footprint data, and automated Watchlist briefings grounded in primary sources.
- Corporate & subsidiary hierarchy
- Competitor & partner network
- Automated Watchlist briefings
Competitors & alternatives
Track competitor shifts
Receive automated telemetry on strategic moves, acquisitions, and market share shifts across KNOREX's competitive landscape.
Programmatic advertising platform for buying, targeting, measuring and creating ads.
Unified DSP and creative automation platform for e-commerce advertisers.
Adtech platform for creative, activation, publisher monetisation, and measurement.
Composable adtech platform for omnichannel media, data and creative.
Omnichannel programmatic adtech platform with managed services and white-label tools.
Side-by-side comparisons
Recent recorded signals
Dates refer to the source publication. Older entries are historical context, not evidence of a new event.
KNOREX Faces Delisting as NYSE American Suspends Class A Ordinary Shares
Regulation & Antitrust · Recorded impact score: 4.5/5
On November 11, 2026, KNOREX Ltd. was notified by NYSE American LLC that the exchange immediately suspended trading in its Class A ordinary shares and commenced proceedings to delist the stock under Section 1003(f)(v) of the NYSE American Company Guide due to an abnormally low selling price. KNOREX intends to appeal the decision by requesting a hearing before the Listing Qualifications Panel prior to the November 18, 2026 deadline. During the appeal, shares will remain suspended from trading. To regain compliance and defend its listing, the company plans to pursue a reverse stock split, though no assurance can be given regarding a successful outcome.
- NYSE American suspended trading in KNOREX Class A ordinary shares on November 11, 2026, and initiated delisting proceedings under Section 1003(f)(v) due to low share price.
- KNOREX must submit its appeal request to the Listing Qualifications Panel by November 18, 2026, to challenge the delisting determination.
6-K Financial Filing Analysis for KNOREX (2026-10-28)
financials · Recorded impact score: 3/5
Knorex Ltd. filed a Form 6-K with the U.S. Securities and Exchange Commission on October 28, 2026, furnishing its unaudited condensed consolidated financial statements and operating and financial review for the six months ended June 30, 2026, and 2025. The filing serves as the company's semi-annual financial disclosure required for foreign private issuers, incorporating interim financial results in Exhibit 99.1 and accompanying management commentary in Exhibit 99.2.
- Knorex furnished unaudited condensed consolidated financial statements and management review for the six-month period ended June 30, 2026, and June 30, 2025, via Exhibits 99.1 and 99.2.
- The filing was authorized and signed by Khar Heng Choo, Chairman of the Board of Directors and Chief Executive Officer, on October 27, 2026.
6-K Financial Filing Analysis for KNOREX (2026-10-08)
financials · Recorded impact score: 3.8/5
On October 2, 2026, KNOREX Ltd. entered into an exchange agreement with North Commerce Parkway Capital LP and TQ Master Fund LP to exchange $3,150,000 in outstanding principal of existing senior unsecured promissory notes for new convertible promissory notes totaling $3,363,411. The new principal incorporates $129,325 in capitalized accrued interest and an $84,086 original issue discount (2.5%). The exchange was executed under Section 3(a)(9) of the Securities Act without additional cash consideration. The newly issued notes mature on January 1, 2027, and are convertible into Class A ordinary shares at a conversion price equal to the greater of 80% of the lowest 5-day VWAP or a floor price set at 20% of the NYSE American minimum price. Furthermore, the agreement mandates 100% prepayment from gross proceeds of future debt or equity financings and asset sales, creating near-term dilution risk and strict liquidity encumbrances ahead of early 2027.
- KNOREX exchanged $3,150,000 in senior unsecured notes for $3,363,411 in new convertible notes due January 1, 2027, reflecting $129,325 in capitalized interest and an $84,086 original issue discount.
- The convertible notes feature a variable conversion price equal to the greater of 80% of the lowest 5-day Daily VWAP and a 20% NYSE American floor price, subject to standard 4.99% (up to 9.99%) ownership blockers.
KNOREX Plans Carve-Out of AscendX Publisher Business
M&A · Recorded impact score: 3/5
KNOREX Ltd., a provider of AI-driven cross-channel programmatic advertising solutions, announced it is pursuing a strategic carve-out of its wholly-owned subsidiary AscendX Media Technologies Pte. Ltd., a publisher monetization platform. Under the proposed structure, AscendX would be independently capitalized with external investment, allowing KNOREX to retain a minority equity interest and eliminate the need to fund AscendX's future growth. Since its formation in June 2025, AscendX has moved into commercial deployment with 10 live publishers, over 2 billion ad impressions in 2026, and integrations with major demand platforms such as The Trade Desk, Meta Audience Network, Microsoft Monetize, OpenX, and Magnite. The carve-out is subject to negotiation and approvals. CEO Phu Le of AscendX will have the transaction reviewed by KNOREX's Audit Committee due to his dual role.
- KNOREX Ltd. is pursuing a strategic carve-out of AscendX Media Technologies Pte. Ltd., its wholly-owned publisher monetization subsidiary.
- AscendX has attracted interest from external investors and is expected to be independently capitalized.
Knorex Files Form F-1 for $50M Equity Line Amid Severe Revenue Decline
M&A & Corporate Finance · Recorded impact score: 4.5/5
Knorex Ltd. filed a Form F-1 registration statement covering the resale of up to 156,787,119 Class A ordinary shares by selling shareholders associated with a committed equity purchase agreement of up to $50 million entered into in March 2026. The company will receive no proceeds from selling shareholder resales, though it may draw up to $50 million in gross proceeds from direct issuances under the equity facility for working capital. The filing reflects critical financial distress, showing that FY 2025 revenue contracted 44.2% year-over-year to $6.04 million due to tariffs impacting its anchor customer's end-clients. Net losses expanded to $11.55 million in FY 2025 from $5.88 million in FY 2024, resulting in a stockholders' deficit of $(6.48) million and cash reserves of just $129,104 against current liabilities of $13.33 million, prompting NYSE American continued listing deficiency notices.
- Files F-1 covering up to 156,787,119 Class A ordinary shares issuable under a $50 million committed equity purchase agreement.
- FY 2025 revenue fell 44.2% year-over-year to $6.04 million from $10.82 million, driven by demand contraction from its largest customer.
Explore company relationships
Questions about KNOREX
What is Knorex?
Knorex is a public B2B adtech company that provides a cross-channel advertising management and execution platform for enterprises and agencies.
Who uses Knorex?
Its main users are enterprise advertisers, in-house marketing teams, programmatic traders and media agencies running campaigns across multiple digital channels.
How does Knorex make money?
It makes money through a mix of software access fees and usage-linked revenue tied to campaign execution, platform utilisation and media buying activity.
Sources & coverage
This profile uses public, official and technically observable information. Missing information does not prove that a product or relationship does not exist. The list below does not imply that every profile statement has been verified.
5 publicly documented primary sources and citations linked across the market graph.
Start with a company or market. Track what changes.
Create your Polaris7 workspace to explore extended company profiles, organize relevant players into Watchlists, and receive focused briefings when material changes occur.
KNOREX
Open extended company details, ownership links, and automated signal monitoring in Polaris7.
